“LGALS3 +191A and +292C polymorphisms are associated with a reduction in serum gal-3 levels, but not with the clinical events of individuals with sickle cell anemia”, RSD, vol. 9, no. 9, p. e442997314, Aug. 2020, doi: 10.33448/rsd-v9i9.7314.